Axon Enterprise (NASDAQ:AXON) Shares Unloaded Rep. Robert Bresnahan, Jr.

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Axon Enterprise, Inc. (NASDAQ:AXON). In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Axon Enterprise stock on January 13th. The trade occurred in the Representative’s “JOINT OWNERSHIP LPL ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Lowe’s Companies (NYSE:LOW) on 2/7/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Take-Two Interactive Software (NASDAQ:TTWO) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 2/3/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Manhattan Associates (NASDAQ:MANH) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 1/29/2025.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $683.41 on Friday. The business’s fifty day moving average price is $623.22 and its two-hundred day moving average price is $506.30. Axon Enterprise, Inc. has a fifty-two week low of $260.27 and a fifty-two week high of $698.67. The stock has a market capitalization of $52.11 billion, a price-to-earnings ratio of 176.59, a price-to-earnings-growth ratio of 6.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. JMP Securities upped their price target on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $542.15.

Insider Activity

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now directly owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is owned by company insiders.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors and hedge funds have recently added to or reduced their stakes in AXON. CWM LLC lifted its position in Axon Enterprise by 1.3% during the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after buying an additional 36 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in shares of Axon Enterprise by 322.6% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 393 shares of the biotechnology company’s stock valued at $157,000 after purchasing an additional 300 shares during the period. NBC Securities Inc. raised its holdings in shares of Axon Enterprise by 2.2% in the 3rd quarter. NBC Securities Inc. now owns 4,287 shares of the biotechnology company’s stock valued at $1,713,000 after purchasing an additional 92 shares during the period. Swedbank AB raised its holdings in shares of Axon Enterprise by 1.7% in the 3rd quarter. Swedbank AB now owns 132,603 shares of the biotechnology company’s stock valued at $52,988,000 after purchasing an additional 2,206 shares during the period. Finally, Magnus Financial Group LLC raised its holdings in shares of Axon Enterprise by 3.2% in the 3rd quarter. Magnus Financial Group LLC now owns 2,280 shares of the biotechnology company’s stock valued at $911,000 after purchasing an additional 70 shares during the period. 79.08% of the stock is owned by institutional investors.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.